Literature DB >> 27617536

THE EFFECT OF INTERNAL LIMITING MEMBRANE PEELING ON IDIOPATHIC EPIRETINAL MEMBRANE SURGERY, WITH A REVIEW OF THE LITERATURE.

Sidney A Schechet1, Eva DeVience, John T Thompson.   

Abstract

PURPOSE: To examine the effect of internal limiting membrane (ILM) removal on epiretinal membrane (ERM) surgery by comparing best-corrected visual acuity (BCVA), optical coherence tomography central macular thickness (CMT) changes, ERM recurrence, and need for repeat surgery.
METHODS: Retrospective study of 251 consecutive patients (251 eyes) who underwent pars plana vitrectomy for idiopathic ERM by a single surgeon with over 1 year of follow-up data. Data were collected preoperatively and postoperatively at 3 months, 1 year, 2 years, and at the last visit. The ILM was not specifically removed in the earlier group of patients and was removed after staining of the ILM in the later group.
RESULTS: One hundred and forty eyes (55.8%) did not have an ILM peel (non-ILM group), and 111 eyes (44.2%) did have an ILM peel (ILM group). There were no significant differences between groups in age, gender, preoperative BCVA, preoperative intraocular pressure, preoperative CMT on optical coherence tomography, and cataract status. Total follow-up time for the ILM group was 32.1 months and 45.4 months for the non-ILM group (P = 0.002). Both groups had improvement in BCVA. The ILM group improved by 12 Early Treatment Diabetic Retinopathy Study letters and the non-ILM group improved by 10.5 Early Treatment Diabetic Retinopathy Study letters. There was no significant difference in the final BCVA (P = 0.18) or total change of BCVA (P = 0.48). Cataract status preoperatively did not affect the total change of BCVA, but being phakic at the most recent visit was associated with a slight loss of visual acuity. Both groups had improvement in optical coherence tomography appearance, for the CMT in the ILM group decreased by 83 μm and the CMT in the non-ILM group decreased by 110 μm. There was no significant difference in the final CMT (P = 0.07); however, the non-ILM group tended to have a lower final CMT. Some degree of ERM recurrence was detected by slit-lamp biomicroscopy in 2 eyes (1.8%) of the ILM group and in 32 eyes (22.9%) of the non-ILM group (P ≤ 0.0001). None of the eyes with ILM removal required repeat vitrectomy, whereas 17 eyes (12.1%) of the non-ILM group did require vitrectomy, showing that ILM removal had a significant effect on the need for repeat vitrectomy (P < 0.0001) between non-ILM versus ILM peel groups.
CONCLUSION: The rate of recurrent ERM and need for repeat ERM surgery is lower in eyes where the ILM is removed with the ERM, whereas BCVA and CMT were similar with or without ILM removal. Complete ILM removal around the macula should be considered for the treatment of eyes with idiopathic ERMs to reduce the incidence of ERM recurrences.

Entities:  

Mesh:

Year:  2017        PMID: 27617536     DOI: 10.1097/IAE.0000000000001263

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  15 in total

1.  [Macular pucker surgery with and without delamination of the internal limiting membrane-a prospective randomized study].

Authors:  M W Storch; M H Khattab; P Lauermann; C Krüger; U Ritzau-Tondrow; R Staudenmaier; J Callizo; H Hoerauf
Journal:  Ophthalmologe       Date:  2019-11       Impact factor: 1.059

Review 2.  [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].

Authors: 
Journal:  Ophthalmologe       Date:  2021-02       Impact factor: 1.059

3.  Comparisons of surgical outcomes after epiretinal membrane peeling in the myopic eyes with long to that with normal axial length.

Authors:  Gen Miura; Takayuki Baba; Tomoaki Tatsumi; Takehito Iwase; Hirotaka Yokouchi; Shuichi Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-10       Impact factor: 3.117

4.  Evaluation of postoperative visual function based on the preoperative inner layer structure in the epiretinal membrane.

Authors:  Hiroko Terashima; Fumiki Okamoto; Hiruma Hasebe; Naoki Matsuoka; Eriko Ueda; Hiromitsu Yoshida; Tetsuya Togano; Takeo Fukuchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-06-07       Impact factor: 3.117

5.  Anatomic and functional results of idiopathic macular epiretinal membrane surgery.

Authors:  Mehmet Ozgur Cubuk; Erkan Unsal
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

Review 6.  The internal limiting membrane: Roles in retinal development and implications for emerging ocular therapies.

Authors:  Kevin Y Zhang; Thomas V Johnson
Journal:  Exp Eye Res       Date:  2021-03-20       Impact factor: 3.467

7.  Analysis of Complications for Epiretinal Membrane and Macular Hole Surgery Performed by Vitreoretinal Fellows and Consultants.

Authors:  Saud Aljohani; Abdulaziz Alshehri; Abdulaziz Al Taisan; Rakan Algorinees; Valmore A Semidey
Journal:  Clin Ophthalmol       Date:  2021-05-07

8.  Three-Dimensional Analysis of Peeled Internal Limiting Membrane Using Focused Ion Beam/Scanning Electron Microscopy.

Authors:  Akira Hirata; Kazuhisa Murata; Ken Hayashi; Kei-Ichiro Nakamura
Journal:  Transl Vis Sci Technol       Date:  2018-02-02       Impact factor: 3.283

9.  Long-term evaluation of spontaneous release of epiretinal membrane and its possible pathogenesis.

Authors:  Teruyo Kida; Seita Morishita; Masanori Fukumoto; Takaki Sato; Hidehiro Oku; Tsunehiko Ikeda
Journal:  Clin Ophthalmol       Date:  2017-09-01

10.  Does internal limiting membrane peeling during epiretinal membrane surgery induce microscotomas on microperimetry? Study protocol for PEELING, a randomized controlled clinical trial.

Authors:  Jean-Baptiste Ducloyer; Juliette Ivan; Alexandra Poinas; Olivier Lebreton; Alexandre Bonissent; Paul Fossum; Christelle Volteau; Ramin Tadayoni; Catherine Creuzot-Garchet; Yannick Le Mer; Julien Perol; June Fortin; Anne Chiffoleau; Fanny Billaud; Catherine Ivan; Michel Weber
Journal:  Trials       Date:  2020-06-08       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.